Cargando…
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
Autologous transplantation of hematopoietic stem cells transduced with a lentiviral vector (LV) expressing an anti-sickling HBB variant is a potential treatment for sickle cell disease (SCD). With a clinical trial as our ultimate goal, we generated LV constructs containing an anti-sickling HBB trans...
Autores principales: | Weber, Leslie, Poletti, Valentina, Magrin, Elisa, Antoniani, Chiara, Martin, Samia, Bayard, Charles, Sadek, Hanem, Felix, Tristan, Meneghini, Vasco, Antoniou, Michael N., El-Nemer, Wassim, Mavilio, Fulvio, Cavazzana, Marina, Andre-Schmutz, Isabelle, Miccio, Annarita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105766/ https://www.ncbi.nlm.nih.gov/pubmed/30140714 http://dx.doi.org/10.1016/j.omtm.2018.07.012 |
Ejemplares similares
-
Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
por: Weber, Leslie, et al.
Publicado: (2020) -
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021) -
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018) -
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
por: Lagresle-Peyrou, Chantal, et al.
Publicado: (2018) -
GATA Factor-Mediated Gene Regulation in Human Erythropoiesis
por: Romano, Oriana, et al.
Publicado: (2020)